Plasma Therapy Market by Type (Pure Platelet-rich Plasma, Platelet-rich Fibrin), Application (Orthopedics, Dermatology, Cosmetology, Rheumatology, Ophthalmology), End User (Hospitals and Clinics, Research Institutes)- Forecast to 2028
Global Platelet Rich Plasma Therapy Market by Type (Pure Platelet-rich Plasma, Platelet-rich Fibrin), Application (Orthopedics, Dermatology, Cosmetology, Rheumatology, Ophthalmology), End User (Hospitals and Clinics, Research Institutes)—Forecast to 2028
The global platelet rich plasma (PRP) therapy market is expected to grow at a CAGR of 12.2% during the forecast period to reach $882.5 million by 2028.
Following a thorough secondary and primary research and in-depth analysis of the market scenario, the report discusses key industry drivers, restraints, challenges, and opportunities.
The growth of this market is mainly attributed to factors such as the advantages offered by PRP treatment, increasing awareness toward PRP therapies, rising prevalence of musculoskeletal, sports, & orthopedic injuries, and the growing number of cosmetic procedures worldwide.
In addition, increasing PRP treatments and advancing healthcare in emerging economies are expected to offer significant growth opportunities for platelet rich plasma therapy providers.
However, the availability of alternatives for PRP treatment and side-effects associated with PRP is expected to restrain the growth of the platelet rich plasma therapy market to some extent during the forecast period. Also, the stringent regulatory framework for PRP use is the major challenging factor observed in this market.
Based on type, the global platelet rich plasma therapy market is segmented into pure PRP, leukocyte–rich PRP, pure platelet-rich fibrin, and leukocyte & platelet rich fibrin. In 2021, the pure PRP segment is estimated to account for the largest share of the global platelet rich plasma therapy market. Pure PRP is advantageous over conventional PRP as it undergoes a two-step concentration process that eliminates red blood cells and neutrophils. Thus, the advantages offered by pure PRP treatment over other pain-relieving and cosmetic treatments are expected to augment the segment's growth during the coming years.
Based on application, the platelet rich plasma therapy market is segmented into orthopedics & traumatology, rheumatology, dermatology and cosmetology, ophthalmology, stomatology and odontology, and other applications. In 2021, the orthopedics and traumatology segment is estimated to account for the largest share of the global platelet rich plasma therapy market. The increasing number of patients suffering from musculoskeletal disorders and increasing recommendation of PRP therapy as a parallel treatment of various disorders such as fractures and chronic pain is expected to drive the demand for PRP for orthopedics and traumatology application in the market.
Based on end user, the global platelet rich plasma therapy market is segmented into hospitals & clinics and research institutes. In 2021, the hospitals & clinics segment is estimated to account for a larger share of the global platelet rich plasma therapy market. The large share of this segment is attributed to the usage of platelet rich plasma therapy by hospitals and clinics for pain management, regenerative medicines, joints & bone surgeries, cosmetic enhancements, hair growth, and sports injuries. PRP treatments are mostly applied to manage accidents and trauma, infectious diseases, orthopedic treatments, cosmetics, dermatology, and hair growth & transplant.
An in-depth analysis of the geographical scenario of the platelet-rich plasma therapy market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. North America is expected to command the largest share of the global platelet-rich plasma therapy market in 2021, followed by Europe and Asia-Pacific.
Key companies operating in the global platelet rich plasma therapy market are Arthrex, Inc. (U.S.), DePuy Synthes Inc. (U.S.), Dr PRP USA LLC (U.S.), EmCyte Corporation (U.S.), Exactech Inc. (U.S.), Global Stem Cells Group, Inc. (U.S.), Celling Biosciences, Inc. (U.S.), Terumo Corporation (Japan), Regen Lab SA (Switzerland), Stryker Corporation (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), and Juventix Regenerative Medical LLC (U.S.).
Scope of the Report
Global Platelet Rich Plasma Therapy Market, by Type
The global platelet rich plasma (PRP) therapy market is expected to grow at a CAGR of 12.2% during the forecast period to reach $882.5 million by 2028.
Following a thorough secondary and primary research and in-depth analysis of the market scenario, the report discusses key industry drivers, restraints, challenges, and opportunities.
The growth of this market is mainly attributed to factors such as the advantages offered by PRP treatment, increasing awareness toward PRP therapies, rising prevalence of musculoskeletal, sports, & orthopedic injuries, and the growing number of cosmetic procedures worldwide.
In addition, increasing PRP treatments and advancing healthcare in emerging economies are expected to offer significant growth opportunities for platelet rich plasma therapy providers.
However, the availability of alternatives for PRP treatment and side-effects associated with PRP is expected to restrain the growth of the platelet rich plasma therapy market to some extent during the forecast period. Also, the stringent regulatory framework for PRP use is the major challenging factor observed in this market.
Based on type, the global platelet rich plasma therapy market is segmented into pure PRP, leukocyte–rich PRP, pure platelet-rich fibrin, and leukocyte & platelet rich fibrin. In 2021, the pure PRP segment is estimated to account for the largest share of the global platelet rich plasma therapy market. Pure PRP is advantageous over conventional PRP as it undergoes a two-step concentration process that eliminates red blood cells and neutrophils. Thus, the advantages offered by pure PRP treatment over other pain-relieving and cosmetic treatments are expected to augment the segment's growth during the coming years.
Based on application, the platelet rich plasma therapy market is segmented into orthopedics & traumatology, rheumatology, dermatology and cosmetology, ophthalmology, stomatology and odontology, and other applications. In 2021, the orthopedics and traumatology segment is estimated to account for the largest share of the global platelet rich plasma therapy market. The increasing number of patients suffering from musculoskeletal disorders and increasing recommendation of PRP therapy as a parallel treatment of various disorders such as fractures and chronic pain is expected to drive the demand for PRP for orthopedics and traumatology application in the market.
Based on end user, the global platelet rich plasma therapy market is segmented into hospitals & clinics and research institutes. In 2021, the hospitals & clinics segment is estimated to account for a larger share of the global platelet rich plasma therapy market. The large share of this segment is attributed to the usage of platelet rich plasma therapy by hospitals and clinics for pain management, regenerative medicines, joints & bone surgeries, cosmetic enhancements, hair growth, and sports injuries. PRP treatments are mostly applied to manage accidents and trauma, infectious diseases, orthopedic treatments, cosmetics, dermatology, and hair growth & transplant.
An in-depth analysis of the geographical scenario of the platelet-rich plasma therapy market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. North America is expected to command the largest share of the global platelet-rich plasma therapy market in 2021, followed by Europe and Asia-Pacific.
Key companies operating in the global platelet rich plasma therapy market are Arthrex, Inc. (U.S.), DePuy Synthes Inc. (U.S.), Dr PRP USA LLC (U.S.), EmCyte Corporation (U.S.), Exactech Inc. (U.S.), Global Stem Cells Group, Inc. (U.S.), Celling Biosciences, Inc. (U.S.), Terumo Corporation (Japan), Regen Lab SA (Switzerland), Stryker Corporation (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), and Juventix Regenerative Medical LLC (U.S.).
Scope of the Report
Global Platelet Rich Plasma Therapy Market, by Type
- Pure Platelet rich Plasma
- Leukocyte-rich PRP
- Platelet-rich Fibrin
- Leukocyte & Platelet rich Fibrin
- Orthopedics and Traumatology
- Dermatology and Cosmetology
- Rheumatology
- Stomatology and Odontology
- Ophthalmology
- Others
- Hospitals and Clinics
- Research Institutes
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe (RoE)
- Asia-Pacific (APAC)
- Japan
- China
- India
- Rest of APAC (RoAPAC)
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM (RoLATAM)
- Middle East & Africa
1. INTRODUCTION
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-Up Approach
2.3.1.2. Top-Down Approach
2.3.1.3. Growth Forecast
2.3.2. Market Share Analysis
2.4. Assumptions for this Study
2.5. Limitations for the Study
3. EXECUTIVE SUMMARY
4. MARKET INSIGHTS
4.1. Drivers
4.1.1. Advantages Offered by PRP Treatment
4.1.2. Increasing Awareness Toward PRP Therapies
4.1.3. Rising Prevalence of Musculoskeletal and Sports Injuries
4.1.4. Growing Number of Cosmetic Procedures Worldwide
4.2. Restraints
4.2.1. Availability of Alternatives for PRP Treatment
4.2.2. Side-Effects Associated with the Use of PRP
4.3. Opportunities
4.3.1. Increasing Applications of PRP Treatments
4.3.2. Advancing Healthcare in Emerging Economies
4.4. Challenge
4.4.1. Stringent Regulatory Framework for the Use of PRP
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of Substitutes
4.5.4. Threat of New Entrants
4.5.5. Competitive Rivalry
5. IMPACT OF COVID-19 ON THE GLOBAL PLATELET RICH PLASMA MARKET
6. PRP QUALIFICATION CRITERIA
7. PRP THERAPY MARKET TRENDS
8. PLATELET RICH PLASMA THERAPY MARKET, BY TYPE
8.1. Introduction
8.2. Pure PRP
8.3. Leukocyte-Rich PRP
8.4. Pure Platelet Rich Fibrin
8.5. Leukocyte And Platelet Rich Fibrin (L-PRF)
9. PLATELET RICH PLASMA (PRP) THERAPY MARKET, BY APPLICATION
9.1. Introduction
9.2. Orthopedics & Traumatology
9.3. Rheumatology
9.4. Dermatology & Cosmetology
9.5. Opthalmology
9.6. Stomatology & Odontology
9.7. Other Applications
10. PLATELET RICH PLASMA THERAPY MARKET, BY END USER
10.1. Introduction
10.2. Hospitals & Clinics
10.3. Research Institutes
11. PLATET RICH PLASMA THERAPY MARKET, BY GEOGRAPHY
11.1. Introduction
11.2. North America
11.2.1. U.S.
11.2.2. Canada
11.3. Europe
11.3.1. Germany
11.3.2. France
11.3.3. U.K.
11.3.4. Italy
11.3.5. Spain
11.3.6. Rest of Europe (RoE)
11.4. Asia-Pacific
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. Rest of Asia-Pacific (RoAPAC)
11.5. Latin America
11.5.1. Brazil
11.5.2. Mexico
11.5.3. Argentina
11.5.4. Rest of Latin America
11.6. Middle East & Africa
12. COMPETITIVE LANDSCAPE
12.1. Introduction
12.2. Key Growth Strategies
12.3. Market Share Analysis (2020)
12.3.1. DePuy Synthes, Inc. (U.S.)
12.3.2. Stryker Corporation (U.S.)
12.3.3. Zimmer Biomet Holdings, Inc. (U.S.)
12.3.4. Terumo Corporation (Japan).
12.4. Key Players SWOT Analysis
12.4.1. Zimmer Biomet Holdings, Inc.
12.4.1.1. Strengths
12.4.1.2. Weaknesses
12.4.1.3. Opportunities
12.4.1.4. Threats
12.4.2. Terumo Corporation
12.4.2.1. Strengths
12.4.2.2. Weaknesses
12.4.2.3. Opportunities
12.4.2.4. Threats
12.4.3. Arthrex, Inc.
12.4.3.1. Strengths
12.4.3.2. Weaknesses
12.4.3.3. Opportunities
12.4.3.4. Threats
12.4.4. DePuy Synthes, Inc. (Johnson &Johnson)
12.4.4.1. Strengths
12.4.4.2. Weaknesses
12.4.4.3. Opportunities
12.4.4.4. Threats
12.4.5. Stryker Corporation
12.4.5.1. Strengths
12.4.5.2. Weaknesses
12.4.5.3. Opportunities
12.4.5.4. Threats
12.5. Funding and Grants Assessment
13. COMPANY PROFILES
13.1. Arthrex, Inc.
13.1.1. Business Overview
13.1.2. Product Portfolio
13.1.3. Strategic Developments
13.2. DePuy Synthes, Inc. (Johnson & Johnson)
13.2.1. Business Overview
13.2.2. Financial Overview
13.2.3. Product Portfolio
13.3. Dr PRP USA LLC
13.3.1. Business Overview
13.3.2. Product Portfolio
13.4. Emcyte Corporation
13.4.1. Business Overview
13.4.2. Product Portfolio
13.4.3. Strategic Developments
13.5. Exactech, Inc.
13.5.1. Business Overview
13.5.2. Financial Overview
13.5.3. Product Portfolio
13.6. Global Stem Cells Group, Inc.
13.6.1. Business Overview
13.6.2. Product Portfolio
13.6.3. Strategic Developments
13.7. Celling Biosciences, Inc
13.7.1. Business Overview
13.7.2. Product Portfolio
13.8. Terumo Corporation
13.8.1. Business Overview
13.8.2. Financial Overview
13.8.3. Product Portfolio
13.9. Regen Lab SA
13.9.1. Business Overview
13.9.2. Product Portfolio
13.10. Stryker Corporation
13.10.1. Business Overview
13.10.2. Financial Overview
13.10.3. Product Portfolio
13.10.4. Strategic Developments
13.11. Zimmer Biomet Holdings, Inc.
13.11.1. Business Overview
13.11.2. Financial Overview
13.11.3. Product Portfolio
13.12. Juventix Regenerative Medical, Llc
13.12.1. Business Overview
13.12.2. Product Portfolio
14. APPENDIX
14.1. Questionnaire
14.2. Available Customization
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-Up Approach
2.3.1.2. Top-Down Approach
2.3.1.3. Growth Forecast
2.3.2. Market Share Analysis
2.4. Assumptions for this Study
2.5. Limitations for the Study
3. EXECUTIVE SUMMARY
4. MARKET INSIGHTS
4.1. Drivers
4.1.1. Advantages Offered by PRP Treatment
4.1.2. Increasing Awareness Toward PRP Therapies
4.1.3. Rising Prevalence of Musculoskeletal and Sports Injuries
4.1.4. Growing Number of Cosmetic Procedures Worldwide
4.2. Restraints
4.2.1. Availability of Alternatives for PRP Treatment
4.2.2. Side-Effects Associated with the Use of PRP
4.3. Opportunities
4.3.1. Increasing Applications of PRP Treatments
4.3.2. Advancing Healthcare in Emerging Economies
4.4. Challenge
4.4.1. Stringent Regulatory Framework for the Use of PRP
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of Substitutes
4.5.4. Threat of New Entrants
4.5.5. Competitive Rivalry
5. IMPACT OF COVID-19 ON THE GLOBAL PLATELET RICH PLASMA MARKET
6. PRP QUALIFICATION CRITERIA
7. PRP THERAPY MARKET TRENDS
8. PLATELET RICH PLASMA THERAPY MARKET, BY TYPE
8.1. Introduction
8.2. Pure PRP
8.3. Leukocyte-Rich PRP
8.4. Pure Platelet Rich Fibrin
8.5. Leukocyte And Platelet Rich Fibrin (L-PRF)
9. PLATELET RICH PLASMA (PRP) THERAPY MARKET, BY APPLICATION
9.1. Introduction
9.2. Orthopedics & Traumatology
9.3. Rheumatology
9.4. Dermatology & Cosmetology
9.5. Opthalmology
9.6. Stomatology & Odontology
9.7. Other Applications
10. PLATELET RICH PLASMA THERAPY MARKET, BY END USER
10.1. Introduction
10.2. Hospitals & Clinics
10.3. Research Institutes
11. PLATET RICH PLASMA THERAPY MARKET, BY GEOGRAPHY
11.1. Introduction
11.2. North America
11.2.1. U.S.
11.2.2. Canada
11.3. Europe
11.3.1. Germany
11.3.2. France
11.3.3. U.K.
11.3.4. Italy
11.3.5. Spain
11.3.6. Rest of Europe (RoE)
11.4. Asia-Pacific
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. Rest of Asia-Pacific (RoAPAC)
11.5. Latin America
11.5.1. Brazil
11.5.2. Mexico
11.5.3. Argentina
11.5.4. Rest of Latin America
11.6. Middle East & Africa
12. COMPETITIVE LANDSCAPE
12.1. Introduction
12.2. Key Growth Strategies
12.3. Market Share Analysis (2020)
12.3.1. DePuy Synthes, Inc. (U.S.)
12.3.2. Stryker Corporation (U.S.)
12.3.3. Zimmer Biomet Holdings, Inc. (U.S.)
12.3.4. Terumo Corporation (Japan).
12.4. Key Players SWOT Analysis
12.4.1. Zimmer Biomet Holdings, Inc.
12.4.1.1. Strengths
12.4.1.2. Weaknesses
12.4.1.3. Opportunities
12.4.1.4. Threats
12.4.2. Terumo Corporation
12.4.2.1. Strengths
12.4.2.2. Weaknesses
12.4.2.3. Opportunities
12.4.2.4. Threats
12.4.3. Arthrex, Inc.
12.4.3.1. Strengths
12.4.3.2. Weaknesses
12.4.3.3. Opportunities
12.4.3.4. Threats
12.4.4. DePuy Synthes, Inc. (Johnson &Johnson)
12.4.4.1. Strengths
12.4.4.2. Weaknesses
12.4.4.3. Opportunities
12.4.4.4. Threats
12.4.5. Stryker Corporation
12.4.5.1. Strengths
12.4.5.2. Weaknesses
12.4.5.3. Opportunities
12.4.5.4. Threats
12.5. Funding and Grants Assessment
13. COMPANY PROFILES
13.1. Arthrex, Inc.
13.1.1. Business Overview
13.1.2. Product Portfolio
13.1.3. Strategic Developments
13.2. DePuy Synthes, Inc. (Johnson & Johnson)
13.2.1. Business Overview
13.2.2. Financial Overview
13.2.3. Product Portfolio
13.3. Dr PRP USA LLC
13.3.1. Business Overview
13.3.2. Product Portfolio
13.4. Emcyte Corporation
13.4.1. Business Overview
13.4.2. Product Portfolio
13.4.3. Strategic Developments
13.5. Exactech, Inc.
13.5.1. Business Overview
13.5.2. Financial Overview
13.5.3. Product Portfolio
13.6. Global Stem Cells Group, Inc.
13.6.1. Business Overview
13.6.2. Product Portfolio
13.6.3. Strategic Developments
13.7. Celling Biosciences, Inc
13.7.1. Business Overview
13.7.2. Product Portfolio
13.8. Terumo Corporation
13.8.1. Business Overview
13.8.2. Financial Overview
13.8.3. Product Portfolio
13.9. Regen Lab SA
13.9.1. Business Overview
13.9.2. Product Portfolio
13.10. Stryker Corporation
13.10.1. Business Overview
13.10.2. Financial Overview
13.10.3. Product Portfolio
13.10.4. Strategic Developments
13.11. Zimmer Biomet Holdings, Inc.
13.11.1. Business Overview
13.11.2. Financial Overview
13.11.3. Product Portfolio
13.12. Juventix Regenerative Medical, Llc
13.12.1. Business Overview
13.12.2. Product Portfolio
14. APPENDIX
14.1. Questionnaire
14.2. Available Customization
LIST OF TABLES
Table 1 Platelet Rich Plasma (PRP) Therapy Market Drivers: Impact Analysis (2021–2028)
Table 2 Top Five Non-Surgical Cosmetic Procedures Performed Worldwide In 2019 and Change As Compared to 2018:
Table 3 Platelet Rich Plasma (PRP) Therapy Market Restraints: Impact Analysis (2021–2028)
Table 4 Products and Their PRP Concentrations of Some of The Leading Companies in the PRP Therapy Market
Table 5 Current Indications for Which PRP Therapy Is Used
Table 6 Ongoing Research in New Medical Fields Regarding PRP Therapy
Table 7 Global Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 8 Global Pure PRP Market Size, by Country/Region, 2019–2028 (USD Million)
Table 9 Global Leukocyte-Rich PRP Market Size, by Country/Region, 2019–2028 (USD Million)
Table 10 Global Pure Platelet Rich Fibrin Market Size, by Country/Region, 2019–2028 (USD Million)
Table 11 Global Leukocyte and Platelet Rich Fibrin Market Size, by Country/Region, 2019–2028 (USD Million)
Table 12 Global Platelet Rich Plasma (PRP) Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 13 List of Clinical Trials with PRP for Orthopedic Applications
Table 14 Key Players offering Platelet Rich Plasma (PRP) Therapy for Orthopedics & Traumatology
Table 15 Platelet Rich Plasma (PRP) Therapy Market Size for Orthopedics & Traumatology, by Country/Region, 2019–2028 (USD Million)
Table 16 Key Players offering Platelet Rich Plasma (PRP) Therapy for Rheumatology
Table 17 Platelet Rich Plasma (PRP) Therapy Market Size for Rheumatology, by Country/Region, 2019–2028 (USD Million)
Table 18 List of Research Trials for Dermatology & Cosmetology
Table 19 Key Players offering Platelet Rich Plasma (PRP) Therapy for Dermatology & Cosmetology
Table 20 Platelet Rich Plasma (PRP) Therapy Market Size for Dermatology & Cosmetology, by Country/Region, 2019–2028 (USD Million)
Table 21 Key Player offering Platelet Rich Plasma (PRP) Therapy for Ophthalmology
Table 22 Platelet Rich Plasma (PRP) Therapy Market Size for Ophthalmology, by Country/Region, 2019–2028 (USD Million)
Table 23 Key Player offering Platelet Rich Plasma (PRP) Therapy for Stomatology & Odontology Application
Table 24 Platelet Rich Plasma (PRP) Therapy Market Size for Stomatology & Odontology, by Country/Region, 2019–2028 (USD Million)
Table 25 Clinical Trials with PRP Therapy in Other Applications
Table 26 Key Players offering Platelet Rich Plasma (PRP) Therapy for Other Applications
Table 27 Platelet Rich Plasma (PRP) Therapy Market Size for Other Applications, by Country/Region, 2019–2028 (USD Million)
Table 28 Global Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 29 Global Platelet Rich Plasma Therapy Market Size for Hospitals & Clinics, by Country/Region, 2019–2028 (USD Million)
Table 30 Various Ongoing Researches for Platelet Rich Plasma
Table 31 Global Platelet Rich Plasma Therapy Market Size for Research Institutes, by Country/Region, 2019–2028 (USD Million)
Table 32 Global Platelet-Rich Plasma Therapy Market Size, by Country/Region, 2019–2028 (USD Million)
Table 33 North America: Platelet Rich Plasma Therapy Market Size, by Country, 2019–2028 (USD Million)
Table 34 North America: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 35 North America: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 36 North America: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 37 U.S.: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 38 U.S.: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 39 U.S.: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 40 Canada: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 41 Canada: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 42 Canada: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 43 Europe: Platelet Rich Plasma Therapy Market Size, by Country/Region, 2019–2028 (USD Million)
Table 44 Europe: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 45 Europe: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 46 Europe: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 47 Germany: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 48 Germany: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 49 Germany: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 50 France: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 51 France: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 52 France: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 53 U.K.: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 54 U.K.: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 55 U.K.: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 56 Italy: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 57 Italy: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 58 Italy: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 59 Spain: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 60 Spain: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 61 Spain: Platelet Rich Plasma Therapy Market Size, by End User 2019–2028 (USD Million)
Table 62 Fertility Rate total (Birth Per Woman)
Table 63 RoE: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 64 RoE: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 65 RoE: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 66 Asia-Pacific: Platelet Rich Plasma Therapy Market Size, by Country/Region, 2019–2028 (USD Million)
Table 67 Asia-Pacific: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 68 Asia-Pacific: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 69 Asia-Pacific: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 70 Japan: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 71 Japan: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 72 Japan: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 73 China: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 74 China: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 75 China: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 76 India: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 77 India: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 78 India: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 79 RoAPAC: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 80 RoAPAC: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 81 RoAPAC: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 82 Health Expenditure Per Capita In Latin American Countries
Table 83 Latin America: Platelet Rich Plasma Therapy Market Size, by Country/Region, 2019–2028 (USD Million)
Table 84 Latin America: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 85 Latin America: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 86 Latin America: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 87 Brazil: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 88 Brazil: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 89 Brazil: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 90 Mexico: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 91 Mexico: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 92 Mexico: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 93 Argentina: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 94 Argentina: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 95 Argentina: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 96 Rest of Latin America: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 97 Rest of Latin America: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 98 Rest of Latin America: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 99 Middle East & Africa: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 100 Middle East & Africa Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 101 Middle East & Africa: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 102 Number of Developments by the Major Players During 2018–2021
Table 103 Few Authorities/Organizations Providing Funding/Grants for Blood-Related Research
Table 104 Grants/Fundings by Various Institutions and Organisations for PRP Studies and Research
Table 1 Platelet Rich Plasma (PRP) Therapy Market Drivers: Impact Analysis (2021–2028)
Table 2 Top Five Non-Surgical Cosmetic Procedures Performed Worldwide In 2019 and Change As Compared to 2018:
Table 3 Platelet Rich Plasma (PRP) Therapy Market Restraints: Impact Analysis (2021–2028)
Table 4 Products and Their PRP Concentrations of Some of The Leading Companies in the PRP Therapy Market
Table 5 Current Indications for Which PRP Therapy Is Used
Table 6 Ongoing Research in New Medical Fields Regarding PRP Therapy
Table 7 Global Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 8 Global Pure PRP Market Size, by Country/Region, 2019–2028 (USD Million)
Table 9 Global Leukocyte-Rich PRP Market Size, by Country/Region, 2019–2028 (USD Million)
Table 10 Global Pure Platelet Rich Fibrin Market Size, by Country/Region, 2019–2028 (USD Million)
Table 11 Global Leukocyte and Platelet Rich Fibrin Market Size, by Country/Region, 2019–2028 (USD Million)
Table 12 Global Platelet Rich Plasma (PRP) Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 13 List of Clinical Trials with PRP for Orthopedic Applications
Table 14 Key Players offering Platelet Rich Plasma (PRP) Therapy for Orthopedics & Traumatology
Table 15 Platelet Rich Plasma (PRP) Therapy Market Size for Orthopedics & Traumatology, by Country/Region, 2019–2028 (USD Million)
Table 16 Key Players offering Platelet Rich Plasma (PRP) Therapy for Rheumatology
Table 17 Platelet Rich Plasma (PRP) Therapy Market Size for Rheumatology, by Country/Region, 2019–2028 (USD Million)
Table 18 List of Research Trials for Dermatology & Cosmetology
Table 19 Key Players offering Platelet Rich Plasma (PRP) Therapy for Dermatology & Cosmetology
Table 20 Platelet Rich Plasma (PRP) Therapy Market Size for Dermatology & Cosmetology, by Country/Region, 2019–2028 (USD Million)
Table 21 Key Player offering Platelet Rich Plasma (PRP) Therapy for Ophthalmology
Table 22 Platelet Rich Plasma (PRP) Therapy Market Size for Ophthalmology, by Country/Region, 2019–2028 (USD Million)
Table 23 Key Player offering Platelet Rich Plasma (PRP) Therapy for Stomatology & Odontology Application
Table 24 Platelet Rich Plasma (PRP) Therapy Market Size for Stomatology & Odontology, by Country/Region, 2019–2028 (USD Million)
Table 25 Clinical Trials with PRP Therapy in Other Applications
Table 26 Key Players offering Platelet Rich Plasma (PRP) Therapy for Other Applications
Table 27 Platelet Rich Plasma (PRP) Therapy Market Size for Other Applications, by Country/Region, 2019–2028 (USD Million)
Table 28 Global Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 29 Global Platelet Rich Plasma Therapy Market Size for Hospitals & Clinics, by Country/Region, 2019–2028 (USD Million)
Table 30 Various Ongoing Researches for Platelet Rich Plasma
Table 31 Global Platelet Rich Plasma Therapy Market Size for Research Institutes, by Country/Region, 2019–2028 (USD Million)
Table 32 Global Platelet-Rich Plasma Therapy Market Size, by Country/Region, 2019–2028 (USD Million)
Table 33 North America: Platelet Rich Plasma Therapy Market Size, by Country, 2019–2028 (USD Million)
Table 34 North America: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 35 North America: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 36 North America: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 37 U.S.: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 38 U.S.: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 39 U.S.: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 40 Canada: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 41 Canada: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 42 Canada: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 43 Europe: Platelet Rich Plasma Therapy Market Size, by Country/Region, 2019–2028 (USD Million)
Table 44 Europe: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 45 Europe: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 46 Europe: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 47 Germany: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 48 Germany: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 49 Germany: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 50 France: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 51 France: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 52 France: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 53 U.K.: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 54 U.K.: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 55 U.K.: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 56 Italy: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 57 Italy: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 58 Italy: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 59 Spain: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 60 Spain: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 61 Spain: Platelet Rich Plasma Therapy Market Size, by End User 2019–2028 (USD Million)
Table 62 Fertility Rate total (Birth Per Woman)
Table 63 RoE: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 64 RoE: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 65 RoE: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 66 Asia-Pacific: Platelet Rich Plasma Therapy Market Size, by Country/Region, 2019–2028 (USD Million)
Table 67 Asia-Pacific: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 68 Asia-Pacific: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 69 Asia-Pacific: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 70 Japan: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 71 Japan: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 72 Japan: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 73 China: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 74 China: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 75 China: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 76 India: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 77 India: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 78 India: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 79 RoAPAC: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 80 RoAPAC: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 81 RoAPAC: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 82 Health Expenditure Per Capita In Latin American Countries
Table 83 Latin America: Platelet Rich Plasma Therapy Market Size, by Country/Region, 2019–2028 (USD Million)
Table 84 Latin America: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 85 Latin America: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 86 Latin America: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 87 Brazil: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 88 Brazil: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 89 Brazil: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 90 Mexico: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 91 Mexico: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 92 Mexico: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 93 Argentina: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 94 Argentina: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 95 Argentina: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 96 Rest of Latin America: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 97 Rest of Latin America: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 98 Rest of Latin America: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 99 Middle East & Africa: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 100 Middle East & Africa Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 101 Middle East & Africa: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 102 Number of Developments by the Major Players During 2018–2021
Table 103 Few Authorities/Organizations Providing Funding/Grants for Blood-Related Research
Table 104 Grants/Fundings by Various Institutions and Organisations for PRP Studies and Research
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 6 Market Size Estimation
Figure 7 Global Platelet Rich Plasma (PRP) Therapy Market Size, by Application, 2021 Vs. 2028 (USD Million)
Figure 8 Global Platelet Rich Plasma (PRP) Therapy Market Size, by Type, 2021 Vs. 2028 (USD Million)
Figure 9 Global Platelet Rich Plasma (PRP) Therapy Market Size, by End User, 2021 Vs. 2028 (USD Million)
Figure 10 Platelet Rich Plasma (PRP) Therapy Market Size, by Geography
Figure 11 Market Dynamics
Figure 12 Porter’s Five forces Analysis: Platelet Rich Plasma Therapy Market
Figure 13 Global Platelet Rich Plasma Therapy Market Size, by Type, 2021-2028 (USD Million)
Figure 14 Global Platelet Rich Plasma (PRP) Therapy Market Size, by Application, 2021 Vs. 2028 (USD Million)
Figure 15 Global Platelet Rich Plasma Therapy Market Size, by End User, 2021–2028 (USD Million)
Figure 16 Number of Research Published over The Years for Platelet Rich Plasma Therapy
Figure 17 Global Platelet Rich Plasma Therapy Market Size, by Geography, 2021–2028 (USD Million)
Figure 18 North America: Platelet Rich Plasma Therapy Market Snapshot
Figure 19 Europe: Platelet Rich Plasma Therapy Market Snapshot
Figure 20 Asia-Pacific: Platelet Rich Plasma Therapy Market Snapshot
Figure 21 Key Growth Strategies Adopted by Leading Players -2018–2021
Figure 22 Platelet Rich Plasma (PRP) Therapy: Competitive Benchmarking by Application
Figure 23 Platelet Rich Plasma (PRP) Therapy: Competitive Benchmarking by Geography
Figure 24 Market Share Analysis: Platelet Rich Plasma (PRP) Therapy Industry, 2020
Figure 30 National Institute of Health, U.S. Funding for Regenerative Medicines, 2013–2022 (USD Million)
Figure 31 Johnson And Johnson: Financial Overview, 2020
Figure 32 Terumo Corporation.: Financial Overview, 2020
Figure 33 Stryker Corporation.: Financial Overview, 2020
Figure 34 Zimmer Biomet Holdings, Inc: Financial Overview, 2020
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 6 Market Size Estimation
Figure 7 Global Platelet Rich Plasma (PRP) Therapy Market Size, by Application, 2021 Vs. 2028 (USD Million)
Figure 8 Global Platelet Rich Plasma (PRP) Therapy Market Size, by Type, 2021 Vs. 2028 (USD Million)
Figure 9 Global Platelet Rich Plasma (PRP) Therapy Market Size, by End User, 2021 Vs. 2028 (USD Million)
Figure 10 Platelet Rich Plasma (PRP) Therapy Market Size, by Geography
Figure 11 Market Dynamics
Figure 12 Porter’s Five forces Analysis: Platelet Rich Plasma Therapy Market
Figure 13 Global Platelet Rich Plasma Therapy Market Size, by Type, 2021-2028 (USD Million)
Figure 14 Global Platelet Rich Plasma (PRP) Therapy Market Size, by Application, 2021 Vs. 2028 (USD Million)
Figure 15 Global Platelet Rich Plasma Therapy Market Size, by End User, 2021–2028 (USD Million)
Figure 16 Number of Research Published over The Years for Platelet Rich Plasma Therapy
Figure 17 Global Platelet Rich Plasma Therapy Market Size, by Geography, 2021–2028 (USD Million)
Figure 18 North America: Platelet Rich Plasma Therapy Market Snapshot
Figure 19 Europe: Platelet Rich Plasma Therapy Market Snapshot
Figure 20 Asia-Pacific: Platelet Rich Plasma Therapy Market Snapshot
Figure 21 Key Growth Strategies Adopted by Leading Players -2018–2021
Figure 22 Platelet Rich Plasma (PRP) Therapy: Competitive Benchmarking by Application
Figure 23 Platelet Rich Plasma (PRP) Therapy: Competitive Benchmarking by Geography
Figure 24 Market Share Analysis: Platelet Rich Plasma (PRP) Therapy Industry, 2020
Figure 30 National Institute of Health, U.S. Funding for Regenerative Medicines, 2013–2022 (USD Million)
Figure 31 Johnson And Johnson: Financial Overview, 2020
Figure 32 Terumo Corporation.: Financial Overview, 2020
Figure 33 Stryker Corporation.: Financial Overview, 2020
Figure 34 Zimmer Biomet Holdings, Inc: Financial Overview, 2020
